exonuclease nanopore sequencing | GenomeWeb

exonuclease nanopore sequencing

NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies said today in its annual report that a commercialization agreement it had with Illumina will terminate on June 30, 2016.

Zhimin Wang, a professor in the School of Agriculture and Biology at Shanghai Jiao Tong University in China, is working on a sequencing approach that uses an exonuclease to cleave off single nucleotides from a DNA molecule and detects them by one of two different types of sensors.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.